Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Matucci

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Frontiers in Immunology|April 17, 2020
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical PhenotypeRiccardo Scarpa, Federica Pulvirenti, Antonio Pecoraro, et al.
Panminerva Medica|March 11, 2022
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life studyEmanuele Vivarelli, Andrea Matucci, Ersilia Lucenteforte, et al.
The World Allergy Organization Journal|April 9, 2024
Management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP): Results from a survey among allergists and clinical immunologists of the North-west and Center Italy Inter-Regional Sections of SIAAIC and otorhinolaryngologists of National IARDiego Bagnasco, Luisa Brussino, Cesare Biagini, et al.
Allergy|July 9, 2025
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position PaperAdam Chaker, Paula Kauppi, Sevim Bavbek, et al.
Pathogens (Basel, Switzerland)|March 28, 2026
Improving Molecular Detection of Tick-Borne Pathogens in Citizen-Collected TicksAndrea Matucci, Salvatore Scarso, Graziana Da Rold, et al.
Allergy|July 28, 2020
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian surveyAndrea Matucci, Marco Caminati, Emanuele Vivarelli, et al.
Kidney International Reports|August 15, 2025
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous NephropathyMarco Allinovi, Maxime Teisseyre, Matteo Accinno, et al.
Clinical and Molecular Allergy : CMA|June 24, 2015
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderlyNicola Scichilone, Maria T Ventura, Matteo Bonini, et al.
JAMA Network Open|July 12, 2023
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug AntibodiesSamuel Bitoun, Signe Hässler, David Ternant, et al.
Allergy|June 6, 2020
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAlessandra Vultaggio, Ioana Agache, Cezmi A Akdis, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Frontiers in Immunology|April 17, 2020
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical PhenotypeRiccardo Scarpa, Federica Pulvirenti, Antonio Pecoraro, et al.
Panminerva Medica|March 11, 2022
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life studyEmanuele Vivarelli, Andrea Matucci, Ersilia Lucenteforte, et al.
The World Allergy Organization Journal|April 9, 2024
Management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP): Results from a survey among allergists and clinical immunologists of the North-west and Center Italy Inter-Regional Sections of SIAAIC and otorhinolaryngologists of National IARDiego Bagnasco, Luisa Brussino, Cesare Biagini, et al.
Allergy|July 9, 2025
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position PaperAdam Chaker, Paula Kauppi, Sevim Bavbek, et al.
Pathogens (Basel, Switzerland)|March 28, 2026
Improving Molecular Detection of Tick-Borne Pathogens in Citizen-Collected TicksAndrea Matucci, Salvatore Scarso, Graziana Da Rold, et al.
Allergy|July 28, 2020
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian surveyAndrea Matucci, Marco Caminati, Emanuele Vivarelli, et al.
Kidney International Reports|August 15, 2025
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous NephropathyMarco Allinovi, Maxime Teisseyre, Matteo Accinno, et al.
Clinical and Molecular Allergy : CMA|June 24, 2015
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderlyNicola Scichilone, Maria T Ventura, Matteo Bonini, et al.
JAMA Network Open|July 12, 2023
Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug AntibodiesSamuel Bitoun, Signe Hässler, David Ternant, et al.
Allergy|June 6, 2020
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAlessandra Vultaggio, Ioana Agache, Cezmi A Akdis, et al.
Pageof 16